[Abnormal uterine hemorrhage in climacteric. Medical management].
Following a review of the literature, the authors examine the drugs which are currently used to treat anomalous uterine bleeding during menopause, illustrating their aims and justifying the rationale underlying their use. They conclude by stating that a satisfactory treatment often does not exist, but it is the task of the specialist to gauge the level and sequence of treatments in order to achieve the hoped-for result.
Porpiglia
M
M
Dipartimento di Scienze Ginecologiche Ostetriche, Università degli Studi, Torino.
Piacentino
R
R
Cellura
A
A
Malara
D
D
Geranio
R
R
Grio
R
R
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002979:Climacteric; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D008593:Menopause; D008796:Metrorrhagia / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D008875:Middle Aged; D017697:Premenopause; D011372:Progestins / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004966:Estrogens, Conjugated (USP); D011372:Progestins; D007987:Gonadotropin-Releasing Hormone